Shouxing Yang
Impact in
-
- Andrographolide Research and Applications
-
- MicroRNA in disease regulation
Papers in
-
- Ubiquitin and proteasome pathways 3
- DNA Repair Mechanisms 1
- Histone Deacetylase Inhibitors Research 1
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Changlong Xu (7 shared papers)Zhanxiong Xue (6 shared papers)Bo Zheng (4 shared papers)Jianzhang Wang (3 shared papers)Chenwei Pan (3 shared papers)Guangrong Lu (5 shared papers)Lei Miao (1 shared paper)Fangyan Wang (2 shared papers)
- Journals
- Lipids in Health and Disease (2 papers)Chemical Engineering Journal (1 paper)Frontiers in Public Health (1 paper)Biochemical and Biophysical Research Communications (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Shouxing Yang
13 papers receiving 296 citations
Peers
Comparison fields: 5 of 59
- Complementary and alternative medicine 26
- Cancer Research 42
- Hepatology 14
- Cell Biology 31
- Pharmacology 15
Countries citing papers authored by Shouxing Yang
This map shows the geographic impact of Shouxing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouxing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouxing Yang more than expected).
Fields of papers citing papers by Shouxing Yang
This network shows the impact of papers produced by Shouxing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouxing Yang. The network helps show where Shouxing Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shouxing Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 47 | |
| 2 | 2020 | 45 | |
| 3 | 2018 | 41 | |
| 4 | 2016 | 40 | |
| 5 | 2019 | 34 | |
| 6 | 2024 | 27 | |
| 7 | 2021 | 15 | |
| 8 | 2017 | 14 | |
| 9 | 2024 | 13 | |
| 10 | 2023 | 8 | |
| 11 | 2017 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2025 | 2 | |
| 14 | 2024 | 0 |
About Shouxing Yang
Shouxing Yang is a scholar working on Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 14 papers that have together received 299 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cellular transport and secretion (2 papers), DNA Repair Mechanisms (1 paper), Cancer Genomics and Diagnostics (1 paper), Advanced Nanomaterials in Catalysis (1 paper), Gallbladder and Bile Duct Disorders (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Complementary and alternative medicine (26 citations), Cancer Research (42 citations), Hepatology (14 citations), Cell Biology (31 citations) and Pharmacology (15 citations). Shouxing Yang has collaborated with scholars based in China and United States. Frequent co-authors include Changlong Xu, Zhanxiong Xue, Bo Zheng, Jianzhang Wang, Chenwei Pan, Guangrong Lu, Lei Miao, Fangyan Wang, Zhenzhen Pan and Lu Chen. Their work appears in journals such as Lipids in Health and Disease, Chemical Engineering Journal, Frontiers in Public Health, Biochemical and Biophysical Research Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.